Monrovia's Xencor Gets Patent on Antibody Technology

Xencor, Inc., of Monrovia, has received "a broad patent covering optimized monoclonal antibody variants and their application for extending in vivo half-life of antibodies." Opinion: I suppose those who need to know understand what that means, but I think it means Xencor has figured out a way to keep antibodies alive and working in people's bodies for longer. http://goo.gl/vueIE

 

- Brad Haugaard